Herein we outline the role of the PI3K pathway in prostate cancer and, in particular, its association with androgen receptor signaling in the pathogenesis and evolution of prostate cancer as well as a review of the clinical utility of PI3K targeting. Here, AR is linked to prostate carcinoma.